 visitante ::
identificación
|
|||||||||||||||
|
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español | |||||||||
| Página principal > Artículos > Artículos publicados > Neurocognitive impairments in eating disorders patients with and without comorbid food addiction |
(Institut d'Investigació Biomèdica de Bellvitge) (Institut d'Investigació Biomèdica de Bellvitge) (Universitat de València. Departament de Psicologia Bàsica) (University of Michigan. Department of Psychology) (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición)| Fecha: | 2025 |
| Descripción: | 15 pàg. |
| Resumen: | Background: Research into the presence of Food Addiction (FA) in Eating Disorders (EDs) has gained increasing attention due to its association with greater symptom severity and poorer treatment outcomes. While the clinical and psychopathological significance of FA in EDs is well established, its neurocognitive impact remains largely unexplored. This study had two primary aims: (1) to examine the psychopathological profile and neurocognitive performance of patients with Eating Disorders (EDs), comparing those with Food Addiction (ED FA+) to those without (ED FA-), alongside a Healthy Control (HC) group; and (2) to explore potential correlations between neurocognitive performance and clinical-psychopathological variables. Methods: The sample consisted of N = 152 female participants that met the following conditions: EDs FA+ (N = 65), EDs FA- (N = 24), and HC (N = 63). All participants completed a comprehensive battery of questionnaires, including the Yale Food Addiction Scale 2. 0. (YFAS-2), and others for the assessment of the eating disorder symptoms, general psychopathology, impulsivity and emotion regulation. Decision-making and inhibitory control were assessed using the Iowa Gambling Task and The Connors Continuous Performance Test II. Results: Neurocognitive differences were moderate, with lower IGT performance in Block 3 and greater CPT variability, especially in the ED FA + group. Although the ED FA + group presented a more severe clinical profile- characterized by heightened eating symptomatology and general psychopathology (ED F - vs. ED FA+: EDI-2 Total score p 0. 001 d 0. 95; SCL-90R Global Severity Index p 0. 008 d 071)-this was not directly associated with greater cognitive impairment. Conclusions: The results underscore the need to assess Food Addiction in ED patients, as its presence may exacerbate symptom severity. Additionally, the results suggest that patients with EDs could benefit from incorporating cognitive rehabilitation into their treatment plans, regardless of FA status. |
| Ayudas: | European Commission 101080219 Agencia Estatal de Investigación PDI2021-124887OB-I00 Instituto de Salud Carlos III DTS22/00072 Instituto de Salud Carlos III FORT23/00032 |
| Nota: | Altres ajuts: BIOREXIA project (EPPermed2024-618), connect care project (PCI2025-163265), and cofounded by FEDER funds/European Regional Development Fund (FEDER), a way to build Europe. CIBERObn is an initiative of ISCIII. FFA is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2024- Programme). RG is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021- Programme) |
| Derechos: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.  |
| Lengua: | Anglès |
| Documento: | Article ; recerca ; Versió acceptada per publicar |
| Publicado en: | Journal of Eating Disorders, Vol. 14 (2026) , art. 12, ISSN 2050-2974 |
